Need Help?

Identification of genomic aberrations in low-grade serous ovarian cancer

Low-grade serous ovarian cancer (LGSOC) is a rare disease that occurs more frequently in younger women compared with high-grade disease. The current treatment is suboptimal, and better understanding of molecular pathogenesis of this disease is needed. In this study, we compared the whole genome sequences of LGSOCs from short-term and long-term survivors (defined as <40 and >60 months, respectively). Our goal was to identify novel genomic aberrations in LGSOC, especially in short-term survivors.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001009626 HiSeq X Ten 28
Publications Citations
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
J Transl Med 20: 2022 606
0